BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $602,703,898 | +38.1% | 15,969,896 | +66.8% | 0.07% | +40.4% |
| Q2 2023 | $436,286,287 | +76.2% | 9,576,081 | +56.8% | 0.05% | +56.7% |
| Q1 2023 | $247,632,587 | +73166.7% | 6,105,400 | -7.9% | 0.03% | -33.3% |
| Q4 2022 | $337,988 | -99.9% | 6,631,084 | +35.1% | 0.04% | +18.4% |
| Q3 2022 | $264,348,000 | -1.9% | 4,908,059 | +17.0% | 0.04% | 0.0% |
| Q2 2022 | $269,341,000 | +18.6% | 4,193,382 | +43.2% | 0.04% | +40.7% |
| Q1 2022 | $227,046,000 | +86.6% | 2,928,104 | +106.6% | 0.03% | +92.9% |
| Q4 2021 | $121,664,000 | +214.0% | 1,417,353 | +194.2% | 0.01% | +180.0% |
| Q3 2021 | $38,741,000 | -24.1% | 481,690 | -24.0% | 0.01% | -16.7% |
| Q2 2021 | $51,012,000 | -48.1% | 633,715 | -45.7% | 0.01% | -53.8% |
| Q1 2021 | $98,354,000 | -55.7% | 1,166,162 | -57.9% | 0.01% | -60.6% |
| Q4 2020 | $222,198,000 | -60.6% | 2,769,184 | -61.1% | 0.03% | -65.3% |
| Q3 2020 | $563,668,000 | -20.5% | 7,126,922 | -13.5% | 0.10% | -30.7% |
| Q2 2020 | $709,269,000 | +10.1% | 8,237,755 | +3.8% | 0.14% | -9.3% |
| Q1 2020 | $644,314,000 | +1251.3% | 7,935,879 | +1291.7% | 0.15% | +1577.8% |
| Q4 2019 | $47,681,000 | -51.3% | 570,216 | -49.1% | 0.01% | -55.0% |
| Q3 2019 | $98,001,000 | -6.4% | 1,120,389 | -12.6% | 0.02% | 0.0% |
| Q2 2019 | $104,719,000 | -5.7% | 1,282,211 | -6.1% | 0.02% | -13.0% |
| Q1 2019 | $111,055,000 | +77.6% | 1,365,824 | +43.8% | 0.02% | +64.3% |
| Q4 2018 | $62,514,000 | -50.1% | 949,769 | -41.6% | 0.01% | -41.7% |
| Q3 2018 | $125,325,000 | -18.5% | 1,625,717 | -21.9% | 0.02% | -25.0% |
| Q2 2018 | $153,679,000 | -10.2% | 2,081,255 | -20.9% | 0.03% | -13.5% |
| Q1 2018 | $171,230,000 | -11.6% | 2,632,656 | -12.1% | 0.04% | -9.8% |
| Q4 2017 | $193,637,000 | -12.2% | 2,995,594 | -15.3% | 0.04% | -16.3% |
| Q3 2017 | $220,517,000 | +27.7% | 3,537,345 | +24.0% | 0.05% | +25.6% |
| Q2 2017 | $172,694,000 | +105.0% | 2,852,530 | +75.6% | 0.04% | +105.3% |
| Q1 2017 | $84,257,000 | -18.4% | 1,624,696 | -30.3% | 0.02% | -24.0% |
| Q4 2016 | $103,301,000 | -20.4% | 2,329,702 | -14.6% | 0.02% | -21.9% |
| Q3 2016 | $129,801,000 | +432.9% | 2,726,919 | +406.3% | 0.03% | +433.3% |
| Q2 2016 | $24,357,000 | -40.9% | 538,643 | -46.3% | 0.01% | -45.5% |
| Q1 2016 | $41,234,000 | +17.9% | 1,003,719 | +9.4% | 0.01% | +22.2% |
| Q4 2015 | $34,986,000 | +11.4% | 917,076 | -4.1% | 0.01% | +12.5% |
| Q3 2015 | $31,406,000 | -91.4% | 956,062 | -81.7% | 0.01% | -90.7% |
| Q2 2015 | $366,061,000 | +10.1% | 5,234,676 | +7.8% | 0.09% | +13.2% |
| Q1 2015 | $332,569,000 | -20.8% | 4,855,038 | -15.3% | 0.08% | -20.8% |
| Q4 2014 | $420,138,000 | -6.8% | 5,732,566 | -8.7% | 0.10% | -10.3% |
| Q3 2014 | $450,607,000 | -22.0% | 6,278,484 | -21.4% | 0.11% | -27.2% |
| Q2 2014 | $577,730,000 | -20.4% | 7,990,688 | -19.0% | 0.15% | -26.5% |
| Q1 2014 | $726,201,000 | +26.7% | 9,869,534 | +19.7% | 0.20% | +22.7% |
| Q4 2013 | $573,364,000 | -29.1% | 8,243,919 | -33.0% | 0.16% | -31.8% |
| Q3 2013 | $808,125,000 | +68.0% | 12,302,093 | +77.2% | 0.24% | +56.2% |
| Q2 2013 | $481,021,000 | – | 6,944,133 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |